FCA
CORT icon

FinTrust Capital Advisors’s Corcept Therapeutics CORT Stock Holding History

FinTrust Capital Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$62K Sell
1,339
-432
-24% -$15.3K 0.01% 520
2024
Q2 		$57.5K Hold
1,771
– – 0.01% 501
2024
Q1 		$44.6K Buy
1,771
+1,348
+319% +$31.8K 0.01% 558
2023
Q4 		$13.7K Sell
423
-552
-57% -$15.2K ﹤0.01% 774
2023
Q3 		$26.6K Buy
+975
New +$28.2K 0.01% 609
2019
Q1 		– Sell
-253
Closed -$3K – 1264
2018
Q4 		$3K Buy
+253
New +$3.34K ﹤0.01% 1035

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return